Sangamo BioSciences (SGMO) stock price, revenue, and financials

Sangamo BioSciences market cap is $1.1 b, and annual revenue was $84.45 m in FY 2018

$1.1 B

SGMO Mkt cap, 07-Nov-2019

$8.1 M

Sangamo BioSciences Revenue Q1, 2019
Sangamo BioSciences Net income (Q1, 2019)-42.2 M
Sangamo BioSciences EBIT (Q1, 2019)-43.9 M
Sangamo BioSciences Cash, 31-Mar-201981 M

Sangamo BioSciences Income Statement

Annual

USDFY, 2013Y, 2014Y, 2015FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

24.1m45.9m39.5m39.5m19.4m36.6m84.5m

Revenue growth, %

90%(14%)(51%)

R&D expense

37.0m67.2m65.6m65.7m114.9m

General and administrative expense

13.8m19.2m26.3m27.2m46.7m

Operating expense total

50.8m86.4m91.9m92.9m161.6m

EBIT

(26.7m)(26.8m)(46.9m)(46.9m)(72.6m)(56.4m)(77.1m)

EBIT margin, %

(111%)(58%)(119%)(119%)(374%)(154%)(91%)

Interest income

1.8m8.3m

Pre tax profit

(54.6m)(68.9m)

Income tax expense

5.7m14.0k

Net Income

(26.6m)(26.4m)(40.7m)(40.7m)(71.7m)(54.6m)(68.9m)

Sangamo BioSciences Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

10.2m6.0m69.5m22.1m49.8m140.4m

Accounts Receivable

3.2m10.4m2.5m5.0m3.3m4.7m

Inventories

Current Assets

97.3m190.9m212.6m149.6m248.4m410.5m

PP&E

1.4m1.5m2.9m6.6m31.1m78.7m

Goodwill

1.6m1.6m1.6m1.6m1.6m40.0m

Total Assets

140.8m243.2m217.2m157.9m286.7m590.4m

Accounts Payable

4.4m8.2m6.3m11.0m21.5m

Short-term debt

Current Liabilities

10.1m20.9m20.1m13.3m44.9m78.5m

Long-term debt

Non-Current Liabilities

2.0m

Total Debt

Total Liabilities

19.1m24.8m21.7m98.8m223.1m

Additional Paid-in Capital

423.2m534.5m561.0m576.4m682.8m929.6m

Retained Earnings

(302.1m)(328.5m)(369.3m)(440.9m)(495.5m)(562.7m)

Total Equity

121.7m206.6m192.4m136.2m187.9m367.3m

Financial Leverage

1.2 x1.2 x1.1 x1.2 x1.5 x1.6 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

80.3m126.8m99.3m11.2m25.3m10.8m34.3m33.0m13.0m28.0m18.5m69.8m29.9m30.7m59.4m39.3m81.0m

Accounts Receivable

4.9m5.4m7.0m8.5m6.6m5.2m7.0m2.6m2.3m1.5m2.4m3.5m3.4m3.6m5.0m5.6m7.3m

Current Assets

126.1m220.2m203.0m173.2m203.9m221.0m227.7m191.1m176.2m148.8m133.8m255.7m242.3m236.3m550.0m468.2m362.6m

PP&E

1.5m1.4m1.6m1.6m3.0m3.2m3.1m3.2m3.0m4.9m7.3m8.3m8.5m33.6m37.2m50.5m18.3m

Goodwill

1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m1.6m39.3m

Total Assets

140.4m255.5m250.8m247.3m238.5m229.9m232.5m197.0m180.9m165.0m146.8m283.0m269.8m281.2m627.7m606.6m542.7m

Accounts Payable

2.7m6.1m5.7m8.0m6.8m9.5m8.9m3.1m7.0m6.3m7.4m9.2m10.1m11.0m14.4m16.4m30.1m

Current Liabilities

7.0m16.4m16.8m19.5m20.0m21.1m22.1m10.1m14.5m13.9m13.1m41.7m42.9m49.4m75.9m74.1m91.1m

Non-Current Liabilities

1.7m

Total Liabilities

14.2m38.1m36.5m37.2m31.0m30.0m29.0m17.6m20.9m21.1m21.1m89.0m83.1m98.8m239.9m226.7m213.5m

Common Stock

1.0m

Additional Paid-in Capital

419.5m526.4m530.3m533.6m540.6m545.2m558.0m564.4m571.5m574.3m582.6m663.4m668.3m696.4m918.2m923.2m934.1m

Retained Earnings

(294.0m)(309.7m)(316.7m)(324.2m)(333.9m)(346.0m)(355.2m)(385.7m)(412.3m)(431.3m)(457.5m)(470.0m)(482.4m)(514.5m)(531.2m)(544.0m)(603.9m)

Total Equity

126.1m217.4m214.4m210.1m207.5m199.9m203.6m179.4m160.0m143.8m125.7m194.0m186.7m182.4m387.9m379.9m329.2m

Financial Leverage

1.1 x1.2 x1.2 x1.2 x1.1 x1.2 x1.1 x1.1 x1.1 x1.1 x1.2 x1.5 x1.4 x1.5 x1.6 x1.6 x1.6 x

Sangamo BioSciences Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(26.6m)(26.4m)(40.7m)(71.7m)(54.6m)(68.9m)

Depreciation and Amortization

569.0k549.0k988.0k997.0k1.5m2.4m

Accounts Receivable

1.0m(7.2m)7.8m(2.1m)1.6m(1.3m)

Inventories

Accounts Payable

269.0k(764.0k)(2.3m)3.2m(6.4m)

Cash From Operating Activities

(19.5m)(5.7m)(33.7m)(65.9m)11.2m37.2m

Purchases of PP&E

(432.0k)(621.0k)(2.4m)(732.0k)(3.8m)(43.1m)

Cash From Investing Activities

(80.9m)(178.1m)

Cash From Financing Activities

76.1m102.2m19.7m337.0k97.5m231.7m

Sangamo BioSciences Ratios

USDY, 2019

Revenue/Employee

26.7k

Financial Leverage

1.6 x

Sangamo BioSciences Employee Rating

3.717 votes
Culture & Values
3.5
Work/Life Balance
4.2
Senior Management
3.4
Salary & Benefits
3.7
Career Opportunities
3.2
Source